The University of Osaka–developed “next-generation microfluidic PCR technology” is leveraged to deliver a rapid and easy-to-use gut microbiome testing service, and to operate a community platform business that connects people with digestive concerns with companies offering products to support gut health. We also provide contract testing services for gut microbiome analysis.
We are a biotech company leveraging technologies from the National Cerebral and Cardiovascular Center, Nagasaki University, and Osaka University. We are developing "BROTHERS," a proprietary technology that pairs a PNA strand with an antisense oligonucleotide (ASO). This PNA acts as a "safeguard" to significantly reduce the toxicity issues common in conventional oligonucleotide therapeutics. We drive growth through a dual-engine business model: advancing our in-house pipeline for intractable diseases and out-licensing our platform via collaborations with pharmaceutical companies.
The heart is an organ upon which life itself depends. With a commitment to providing new treatment options for heart failure and saving many lives, iHeart Japan is developing regenerative medicine products using iPS cells. Our product, IHJ-301, combines cells derived from iPS cells, including cardiomyocytes and endothelial cells, with a biomaterial, enabling long-term survival following implantation onto the heart and is expected to deliver strong therapeutic efficacy. Going forward, we plan to commercialize this product in Japan and internationally, with the aim of realizing a society in which patients can be saved without heart transplantation.
A startup overcoming challenges in exosome purification with proprietary high-purity, high-yield technology, offering end-to-end support from research to manufacturing. It accelerates practical applications in drug discovery, contributing to a new foundation for pharmaceutical development and driving medical innovation.
Leveraging unique technology for creating novel microalgae strains from the environment, we provide microalgae strains useful for industrial and academic applications. Additionally, we offer; 1: consultation on microalgae business plans and experimental designs, 2: guidance on microalgae cultivation techniques, and 3: evaluation of microalgae strains based on growth rate and produced substances. We collaborate with diverse companies—spanning aquaculture, food, semiconductors, chemical materials, pet supplies, and rare metal recovery—as well as universities and research institutions to create new industries that address global challenges.
